Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Narjiss Berrada"'
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 2014, Iss 8, Pp 77-80 (2014)
Externí odkaz:
https://doaj.org/article/4e053f28414d415e9ed01a54c6a77df2
Autor:
Abdelilah Laraqui, Basma Elkhannousi, Fouzia Mamouch, Tahar Bajjou, Hassan Errihani, Yassine Sekhsokh, Hicham El Rhaffouli, Narjiss Berrada
Publikováno v:
Annals of Cancer Research and Therapy. 29:153-160
Autor:
Hassan Errihani, Hind Mrabti, Souha Sahraoui, Halima Abahssain, Hamza Ettahri, Ghislaine Raiss, Mouna Bourhafour, Narjiss Berrada
Publikováno v:
Future Oncology
Management of cancer patients during the COVID-19 pandemic is a worldwide challenge – in particular in developing countries where the risk of saturation of health facilities and intensive care beds must be minimized. The first case of COVID-19 was
Publikováno v:
World Journal of Oncology
The multidisciplinary management of inflammatory breast cancer (IBC), which is the most aggressive form of breast cancer due to its rapid proliferation, has changed over the past three decades thanks to advances in medical treatments that represent t
Autor:
Hassan Jouhadi, Kamal Lahbabi, Narjiss Berrada, Hassan Errihani, Meryem Glaoui, Mouna Khouchani, A Acharki
Publikováno v:
Journal of Clinical Oncology. 38:e13024-e13024
e13024 Background: Hertraz, the first trastuzumab biosimilar was approved in Morocco in 2017. Real world data on trastuzumab biosimilars are very limited or not available. HERLife is a prospective, non-interventional phase IV study program that inves
Autor:
Halima Abahsain, Saif Afkir, Mohammed Ichou, Naoufal Mellas, Rizlane Belbaraka, Wafa Allam, Nabil Ismaili, Saber Boutayeb, Amina Taleb, Omar El Mesbahi, Narjiss Berrada, Hassan Errihani
Publikováno v:
ISRN Oncology
Objective. To determine the current shortfall of medical oncologists (MOs) and the projected supply. Background. Morocco, the medical oncology (MO) is a relatively new specialty. Medical oncology was recognized as a separate specialty in 1994 but the
Autor:
Ahmed Zidouh, Samira El Fakir, Narjiss Berrada, Youssef Bensouda, Hind Mrabti, Omar El Mesbahi, Mounia Amziren, Ibrahim Elghissassi, Saber Boutayeb, Chakib Nejjari, Halima Abahssain, Maria Bennani, Hassan Errihani, Abdellatif Benider, Rachid Bekkali, Nawfel Mellas
Publikováno v:
BMC Gastroenterology
Background A multicentre cohort study was held in Morocco, designed to evaluate the quality of life of cancer patients. The aim of this paper is to report the assessment of the quality of life of early colorectal cancer patients, before and after can
Autor:
Sihame, Lkhoyaali, Meryem, Ait El Haj, Mohamed Reda, Khmamouche, Narjiss, Berrada, Hassan, Errihani
Publikováno v:
La Tunisie medicale. 93(8-9)
Announcing cancer to a patient is not a simple task. Usually doctors fail to inform patients about the diagnosis and it is more likely in older people .The need of information in cancerous elderly is not well established. In developed countries, ther
Autor:
Abdelilah Laraqui, Basma Elkhanoussi, H. Hachi, Yassine Sekhsokh, Narjiss Berrada, Saber Boutayeb, Siham Lemsanes, Hassan Errihani, Hind Mrabti, Fouzia Mamouch, Ibrahim El Ghissassi, Mustapha Elkabous
Publikováno v:
Journal of Clinical Oncology. 36:e13064-e13064
e13064Background: Inflammatory breast cancer (IBC) is the most aggressive breast carcinoma, with the clinical and biological characteristics of a rapidly proliferating disease. A number of molecula...
Autor:
Narjiss Berrada, Hassan Errihani, Sihame Ougellit, Hind Mrabti, El Kabous Mustapha, Othman Akkar, Khadija Bellahammou, Asmaa Lakhdissi, Sarra Akla
Publikováno v:
Journal of Clinical Oncology. 35:173-173
173 Background: For reproductive-aged breast cancer (BC) patients, contraception is needed during and after treatment. Few data are available concerning the methods used in the real life and the comprehension of patients. The main objective of our st